Switzerland
· Delayed Price · Currency is CHF Newron Pharmaceuticals Statistics
Total Valuation
SWX:NWRN has a market cap or net worth of CHF 197.59 million. The enterprise value is 232.89 million.
| Market Cap | 197.59M |
| Enterprise Value | 232.89M |
Important Dates
The next estimated earnings date is Tuesday, April 1, 2025.
| Earnings Date | Apr 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SWX:NWRN has 19.96 million shares outstanding. The number of shares has increased by 2.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.96M |
| Shares Change (YoY) | +2.01% |
| Shares Change (QoQ) | +4.02% |
| Owned by Insiders (%) | 5.40% |
| Owned by Institutions (%) | 5.64% |
| Float | 18.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.36 |
| PS Ratio | 26.86 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.85 |
| EV / Sales | 34.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -18.08 |
Financial Position
The company has a current ratio of 3.73
| Current Ratio | 3.73 |
| Quick Ratio | 3.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.65 |
| Interest Coverage | -3.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -33.24% |
| Return on Invested Capital (ROIC) | -42.51% |
| Return on Capital Employed (ROCE) | -76.72% |
| Revenue Per Employee | 305,039 |
| Profits Per Employee | -824,130 |
| Employee Count | 22 |
| Asset Turnover | 0.25 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.18% in the last 52 weeks. The beta is 0.54, so SWX:NWRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +17.18% |
| 50-Day Moving Average | 9.39 |
| 200-Day Moving Average | 8.58 |
| Relative Strength Index (RSI) | 48.46 |
| Average Volume (20 Days) | 73,402 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:NWRN had revenue of CHF 6.71 million and -18.13 million in losses. Loss per share was -1.00.
| Revenue | 6.71M |
| Gross Profit | 6.71M |
| Operating Income | -14.45M |
| Pretax Income | -18.11M |
| Net Income | -18.13M |
| EBITDA | -14.32M |
| EBIT | -14.45M |
| Loss Per Share | -1.00 |
Balance Sheet
The company has 11.73 million in cash and 47.03 million in debt, giving a net cash position of -35.30 million or -1.77 per share.
| Cash & Cash Equivalents | 11.73M |
| Total Debt | 47.03M |
| Net Cash | -35.30M |
| Net Cash Per Share | -1.77 |
| Equity (Book Value) | -29.69M |
| Book Value Per Share | -1.56 |
| Working Capital | 14.16M |
Cash Flow
In the last 12 months, operating cash flow was -12.87 million and capital expenditures -9,628, giving a free cash flow of -12.88 million.
| Operating Cash Flow | -12.87M |
| Capital Expenditures | -9,628 |
| Free Cash Flow | -12.88M |
| FCF Per Share | -0.65 |
Margins
Gross margin is 100.00%, with operating and profit margins of -215.29% and -270.17%.
| Gross Margin | 100.00% |
| Operating Margin | -215.29% |
| Pretax Margin | -269.80% |
| Profit Margin | -270.17% |
| EBITDA Margin | -213.41% |
| EBIT Margin | -215.29% |
| FCF Margin | n/a |
Dividends & Yields
SWX:NWRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.01% |
| Shareholder Yield | -2.01% |
| Earnings Yield | -9.18% |
| FCF Yield | -6.52% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:NWRN has an Altman Z-Score of -0.43. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.43 |
| Piotroski F-Score | n/a |